Literature DB >> 27568058

Low-intensity repetitive magnetic stimulation lowers action potential threshold and increases spike firing in layer 5 pyramidal neurons in vitro.

Alexander D Tang1, Ivan Hong2, Laura J Boddington3, Andrew R Garrett4, Sarah Etherington2, John N J Reynolds3, Jennifer Rodger5.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has become a popular method of modulating neural plasticity in humans. Clinically, rTMS is delivered at high intensities to modulate neuronal excitability. While the high-intensity magnetic field can be targeted to stimulate specific cortical regions, areas adjacent to the targeted area receive stimulation at a lower intensity and may contribute to the overall plasticity induced by rTMS. We have previously shown that low-intensity rTMS induces molecular and structural plasticity in vivo, but the effects on membrane properties and neural excitability have not been investigated. Here we investigated the acute effect of low-intensity repetitive magnetic stimulation (LI-rMS) on neuronal excitability and potential changes on the passive and active electrophysiological properties of layer 5 pyramidal neurons in vitro. Whole-cell current clamp recordings were made at baseline prior to subthreshold LI-rMS (600 pulses of iTBS, n=9 cells from 7 animals) or sham (n=10 cells from 9 animals), immediately after stimulation, as well as 10 and 20min post-stimulation. Our results show that LI-rMS does not alter passive membrane properties (resting membrane potential and input resistance) but hyperpolarises action potential threshold and increases evoked spike-firing frequency. Increases in spike firing frequency were present throughout the 20min post-stimulation whereas action potential (AP) threshold hyperpolarization was present immediately after stimulation and at 20min post-stimulation. These results provide evidence that LI-rMS alters neuronal excitability of excitatory neurons. We suggest that regions outside the targeted region of high-intensity rTMS are susceptible to neuromodulation and may contribute to rTMS-induced plasticity.
Copyright © 2016 IBRO. All rights reserved.

Entities:  

Keywords:  Intermittent Theta Burst Stimulation; action potential threshold; low-intensity rMS; spike firing frequency

Mesh:

Year:  2016        PMID: 27568058     DOI: 10.1016/j.neuroscience.2016.08.030

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  A Preclinical Study of Standard Versus Accelerated Transcranial Magnetic Stimulation for Depression in Adolescents.

Authors:  Bhedita J Seewoo; Lauren A Hennessy; Liz A Jaeschke; Leah A Mackie; Sarah J Etherington; Sarah A Dunlop; Paul E Croarkin; Jennifer Rodger
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-12-31       Impact factor: 3.031

Review 2.  Precise Modulation Strategies for Transcranial Magnetic Stimulation: Advances and Future Directions.

Authors:  Gangliang Zhong; Zhengyi Yang; Tianzi Jiang
Journal:  Neurosci Bull       Date:  2021-10-05       Impact factor: 5.203

3.  The effects of repetitive transcranial magnetic stimulation in an animal model of tinnitus.

Authors:  Wilhelmina H A M Mulders; Vanessa Vooys; Kalina Makowiecki; Alex D Tang; Jennifer Rodger
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

4.  Low intensity repetitive transcranial magnetic stimulation modulates skilled motor learning in adult mice.

Authors:  Alexander D Tang; William Bennett; Claire Hadrill; Jessica Collins; Barbora Fulopova; Karen Wills; Aidan Bindoff; Rohan Puri; Michael I Garry; Mark R Hinder; Jeffery J Summers; Jennifer Rodger; Alison J Canty
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

5.  Low-intensity transcranial magnetic stimulation promotes the survival and maturation of newborn oligodendrocytes in the adult mouse brain.

Authors:  Carlie L Cullen; Matteo Senesi; Alexander D Tang; Mackenzie T Clutterbuck; Loic Auderset; Megan E O'Rourke; Jennifer Rodger; Kaylene M Young
Journal:  Glia       Date:  2019-04-16       Impact factor: 7.452

Review 6.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

Review 7.  Releasing the Cortical Brake by Non-Invasive Electromagnetic Stimulation? rTMS Induces LTD of GABAergic Neurotransmission.

Authors:  Maximilian Lenz; Andreas Vlachos
Journal:  Front Neural Circuits       Date:  2016-11-28       Impact factor: 3.492

8.  Low-intensity repetitive transcranial magnetic stimulation requires concurrent visual system activity to modulate visual evoked potentials in adult mice.

Authors:  Kalina Makowiecki; Andrew Garrett; Alan R Harvey; Jennifer Rodger
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

9.  Resting-state fMRI study of brain activation using low-intensity repetitive transcranial magnetic stimulation in rats.

Authors:  Bhedita J Seewoo; Kirk W Feindel; Sarah J Etherington; Jennifer Rodger
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

Review 10.  rTMS-Induced Changes in Glutamatergic and Dopaminergic Systems: Relevance to Cocaine and Methamphetamine Use Disorders.

Authors:  Jessica Moretti; Eugenia Z Poh; Jennifer Rodger
Journal:  Front Neurosci       Date:  2020-03-06       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.